HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Approaches towards fighting the COVID‑19 pandemic (Review).

Abstract
The coronavirus disease 2019 (COVID‑19) outbreak, which has caused >46 millions confirmed infections and >1.2 million coronavirus related deaths, is one of the most devastating worldwide crises in recent years. Infection with COVID‑19 results in a fever, dry cough, general fatigue, respiratory symptoms, diarrhoea and a sore throat, similar to those of acute respiratory distress syndrome. The causative agent of COVID‑19, SARS‑CoV‑2, is a novel coronavirus strain. To date, remdesivir has been granted emergency use authorization for use in the management of infection. Additionally, several efficient diagnostic tools are being actively developed, and novel drugs and vaccines are being evaluated for their efficacy as therapeutic agents against COVID‑19, or in the prevention of infection. The present review highlights the prevalent clinical manifestations of COVID‑19, characterizes the SARS‑CoV‑2 viral genome sequence and life cycle, highlights the optimal methods for preventing viral transmission, and discusses possible molecular pharmacological mechanisms and approaches in the development of anti‑SARS‑CoV‑2 therapeutic agents. In addition, the use of traditional Chinese medicines for management of COVID‑19 is discussed. It is expected that novel anti‑viral agents, vaccines or an effective combination therapy for treatment/management of SARS‑CoV‑2 infection and spread therapy will be developed and implemented in 2021, and we would like to extend our best regards to the frontline health workers across the world in their fight against COVID‑19.
AuthorsShih-Chang Tsai, Chi-Cheng Lu, Da-Tian Bau, Yu-Jen Chiu, Yu-Ting Yen, Yuan-Man Hsu, Chih-Wei Fu, Sheng-Chu Kuo, Yu-Shiang Lo, Hong-Yi Chiu, Yu-Ning Juan, Fuu-Jen Tsai, Jai-Sing Yang
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 47 Issue 1 Pg. 3-22 (01 2021) ISSN: 1791-244X [Electronic] Greece
PMID33236131 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
Topics
  • Antiviral Agents (therapeutic use)
  • COVID-19 (epidemiology, genetics, pathology)
  • Humans
  • Medicine, Chinese Traditional
  • Pandemics
  • SARS-CoV-2 (genetics, metabolism)
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: